id: NEW:dexmedetomidine_adjunctive_therapy_to_NEW:bradycardia_incidence
name: Dexmedetomidine Adjunctive Therapy â†’ Bradycardia Incidence
from_node:
  node_id: NEW:dexmedetomidine_adjunctive_therapy
  node_name: Dexmedetomidine Adjunctive Therapy
to_node:
  node_id: NEW:bradycardia_incidence
  node_name: Bradycardia Incidence
direction: positive
category: biological
mechanism_pathway:
- 'Step 1: Dexmedetomidine acts as a highly selective alpha-2 adrenergic agonist'
- 'Step 2: Alpha-2 receptor activation reduces sympathetic outflow from the central nervous system'
- 'Step 3: Decreased sympathetic tone leads to reduced heart rate'
- 'Step 4: Excessive reduction in heart rate manifests as bradycardia requiring clinical monitoring'
evidence:
  quality_rating: A
  n_studies: 12
  primary_citation: 'E. T. Polintan et al. 2022. "Adjunctive Dexmedetomidine in Alcohol Withdrawal Syndrome:
    A Systematic Review and Meta-analysis of Retrospective Cohort Studies and Randomized Controlled Trials."
    https://doi.org/10.1177/10600280221130458'
  supporting_citations:
  - Additional citations require full-text access - systematic review included 12 studies
  - Both RCT and cohort subgroups analyzed for adverse events
  - Multiple studies reporting cardiovascular adverse effects of dexmedetomidine
  doi: 10.1177/10600280221130458
  citation_verified: true
last_updated: '2025-12-06'
version: '2.0'
description: Adjunctive dexmedetomidine therapy is associated with significantly higher incidence of bradycardia
  compared to benzodiazepine therapy alone in both RCT and cohort subgroups.
structural_competency:
  equity_implications: The cardiovascular adverse effects of dexmedetomidine require intensive monitoring
    capacity, potentially limiting its use in under-resourced healthcare settings. This creates disparities
    in access to potentially beneficial AWS treatment options based on hospital infrastructure and staffing
    levels.
llm_metadata:
  extracted_by: claude-opus-4-5-20251101
  extraction_date: '2025-12-06T21:12:36.329600'
  extraction_confidence: medium
  prompt_version: 2.1-canonical-validated
